The New York-based firm reported total revenue of approximately $1.5 million for the quarter ending June 30, 2026, a milestone for the company as it pivots away from legacy assets. The bulk of this income, roughly $1.3 million, stemmed from its locking-as-a-service (LaaS) offering launched in April. This service allows the company to lock Canton Coin (CC) on behalf of customers to help them meet network compliance requirements, earning fees through interest, network rewards, or equity grants. An additional $191,226 was earned through its role as a Super Validator on the network.

CEO Mark Wendland stated that the company is pursuing a diversified strategy to capitalize on the digitization of financial markets. Alongside these operational gains, Canton Strategic streamlined its portfolio by selling its legacy biotechnology subsidiary, Gravitas Life Sciences, for a $3.5 million promissory note. Despite these developments, the company reported a net loss of $19.2 million for the quarter, largely driven by a $23.7 million unrealized loss on its digital asset holdings. To bolster governance, the company also recently appointed Sean Galvin, Pamela L. Carter, and Rishi Nangalia to its Board of Directors.